Fast-track neuropathological screening for neurodegenerative diseases

Authors

  • Benjamin Englert Department of Pathology, University of Helsinki and HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland; Center for Neuropathology and Prion Research, Faculty of Medicine, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
  • Sigrun Roeber Center for Neuropathology and Prion Research, Faculty of Medicine, LMU Munich, Munich, Germany
  • Thomas Arzberger Center for Neuropathology and Prion Research, Faculty of Medicine, LMU Munich, Munich, Germany; Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany
  • Viktoria Ruf Center for Neuropathology and Prion Research, Faculty of Medicine, LMU Munich, Munich, Germany
  • Otto Windl Center for Neuropathology and Prion Research, Faculty of Medicine, LMU Munich, Munich, Germany
  • Jochen Herms Center for Neuropathology and Prion Research, Faculty of Medicine, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany

DOI:

https://doi.org/10.17879/freeneuropathology-2024-5643

Keywords:

Neuropathology, Dementia, Movement disorders, Prion disease, Alzheimer disease, Lewy body disease

Abstract

Background: The postmortem diagnostic of individuals having suffered presumptive neurodegenerative disease comprises exclusion of a prion disease, extensive brain sampling and histopathological evaluation, which are resource-intensive and time consuming. To exclude prion disease and to achieve prompt accurate preliminary diagnosis, we developed a fast-track procedure for the histopathological assessment of brains from patients with suspected neurodegenerative disease.

Methods: Based on the screening of two brain regions (frontal cortex and cerebellum) with H&E and six immunohistochemical stainings in 133 brain donors, a main histopathological diagnosis was established and compared to the final diagnosis made after a full histopathological work-up according to our brain bank standard procedure.

Results: In over 96 % of cases there was a concordance between the fast-track and the final main neuropathological diagnosis. A prion disease was identified in four cases without prior clinical suspicion of a prion infection.

Conclusion: The fast-track screening approach relying on two defined, easily accessible brain regions is sufficient to obtain a reliable tentative main diagnosis in individuals with neurodegenerative disease and thus allows for a prompt feedback to the physicians. However, a more thorough histological work-up taking into account the clinical history and the working diagnosis from fast-track screening is necessary for accurate staging and for assessment of co-pathologies.

Metrics

Metrics Loading ...

Downloads

Published

2024-08-06

How to Cite

Englert, B., Roeber, S., Arzberger, T., Ruf, V., Windl, O., & Herms, J. (2024). Fast-track neuropathological screening for neurodegenerative diseases. Free Neuropathology, 5, 16. https://doi.org/10.17879/freeneuropathology-2024-5643

Issue

Section

Original Papers